Brief: Uni-Bio Science Group Says Marketing Application Of Isavuconazonium- Sulfate Capsules Accepted NMPA
18/07/2025 11:25
July 18 (Reuters) - Uni-Bio Science Group Ltd 0690.HK: MARKETING APPLICATION OF ISAVUCONAZONIUM- SULFATE CAPSULES HAS BEEN OFFICIALLY ACCEPTED- BY NMPA Further company coverage: 0690.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Uni-Bio Science
See all newsBrief: Uni-Bio Science Signs Agreement With WMU NERC And Wenzhou Ouhai District Government
Brief: Uni-Bio Science's Unit Expands Global Reach Of Bogutai Through Strategic Partnership
Brief: Uni-Bio Science Group Says Marketing Application Of Isavuconazonium- Sulfate Capsules Accepted NMPA
Brief: Uni-Bio Science Group Says Marketing Application Of Diquafosol Sodium Eye Drops Officially Approved By NMPA
Brief: Uni-Bio Science Declares Final Dividend Of Hk0.277 Cents Per Share